Birdwatch Note Rating
2024-05-30 17:50:56 UTC - HELPFUL
Rated by Participant: F71E445C941A54B0A77A81B7C972B608C7CA443CD1680D1C775D0315D8C683C5
Participant Details
Original Note:
While the court admission by AstraZeneca is a notable development, it is not the first time the potential for rare blood clots associated with the vaccine has been recognized. Health authorities had identified and communicated this risk as early as 2021. https://www.factcheck.org/2024/05/scicheck-misleading-claims-on-well-known-rare-risk-of-astrazeneca-covid-19-vaccine/ https://www.ema.europa.eu/en/news/astrazenecas-covid-19-vaccine-benefits-and-risks-context https://www.ema.europa.eu/en/news/astrazeneca-covid-19-vaccine-review-very-rare-cases-unusual-blood-clots-continues https://www.ema.europa.eu/en/news/astrazenecas-covid-19-vaccine-ema-finds-possible-link-very-rare-cases-unusual-blood-clots-low-blood-platelets https://www.telegraph.co.uk/news/2024/04/28/astrazeneca-admits-covid-vaccine-causes-rare-side-effect/
All Note Details